Skip to main content

Business Intelligence

By HIMSS TV | 06:00 am | July 03, 2024
Massive chain cyberattacks, including those against Change and Ascension, have shed new light on the power of these incidents to trigger multiple cyber insurance policies, says Hartmut Mai, president of Cyberwrite.
HIMSS24
By HIMSS TV | 04:55 pm | July 02, 2024
Dr. Nada Milosavljevic, CMO of startup Safe Health, recommends being comfortable with being uncomfortable to achieve success.  
By HIMSS TV | 06:00 am | June 26, 2024
Piction Health partnered with over 200 dermatologists worldwide to build a data set across skin tones, says CEO and cofounder Susan Conover.  
By Nathan Eddy | 05:25 pm | June 23, 2024
Financial challenges remain a significant concern, with 81% of leaders noting a direct impact on patients, Philips' report reveals.
HIMSS24
By HIMSS TV | 01:00 pm | June 20, 2024
Paul Contino, University Hospital CIO, says HIMSS has helped him in his career, and now he's giving back as a chapter leader for HIMSS in New Jersey by serving on the HIMSS Global Health Education Committee and as chair of that committee.
By Jeff Lagasse | 10:41 am | June 19, 2024
A Medicare beneficiary who takes at least one medication available through RxPass could save approximately $70 per year, retailer says.
By HIMSS TV | 06:00 am | June 19, 2024
When a larger company buys a smaller company in the same industry, this "tuck-in acquisition" is relatively safe, says Aytan Dahukey, partner and leader of Sheppard Mullin's private equity team as well as a member of the firm's healthcare and emerging growth/venture capital teams.  
By Susan Morse | 01:51 pm | June 18, 2024
AHIP panelist Terry Douglas of Surescripts talks about what this means for payers, providers, pharma and others.
By Jeff Lagasse | 11:22 am | June 18, 2024
Blue Shield of California will partner with Included Health to provide support and service to about 400,000 CalPERS PPO members.
By Jeff Lagasse | 10:55 am | June 14, 2024
The Corporate Crimes Against Health Care Act would introduce legal consequences for over-aggressive private equity dealmaking.